Proposed Bipartisan Legislation Would Create First Federally Funded Program to Address Children’s Vision and Eye Health

By Staff
Friday, May 17, 2024 12:18 AM CHICAGO—Prevent Blindness, a nonprofit eye health and safety organization, said it is strongly urging the House and Senate to quickly pass the Early Detection of Vision Impairments for Children (EDVI) Act to improve eyecare access, eye disease diagnosis and treatment for children aged 2-17 years. The legislation, which has been introduced in the U.S. House of Representatives, seeks to establish grants for states and communities to improve children’s vision and eye health through coordinated systems of care, according to an announcement from Prevent Blindness.

Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on Products and Its Myopia Program

By Staff
Thursday, May 16, 2024 12:21 AM NEW YORK—Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, has announced its financial and operating results for the quarter ended March 31, 2024.

Deadline Is Extended to May 22 for Jobson’s 2024 'Ultimate Partners' Program—Nominate a Supportive Business Partner Now

By Staff
Thursday, May 16, 2024 12:15 AM NEW YORK—The readers of Vision Monday and 20/20 Magazine are being asked once again to share nominations to tell their stories for the Ultimate Partners annual editorial initiative. The deadline for submissions has been extended to May 22. Now in its fourth year, Jobson’s 2024 Ultimate Partners program allows readers to highlight their great business support partners and showcase their support. Open to all eyecare professionals, the program is looking to spotlight your most successful collaborations and celebrate the crucial support shared during both challenges and opportunities.

Canadian Seniors Are at Risk of Vision Loss Due to Financial Barriers, Specsavers Survey Reveals

By Staff
Wednesday, May 15, 2024 1:20 PM Canadian seniors are finding it too expensive to maintain a regular eye exam schedule. A new Specsavers survey, conducted by Leger, found that despite provincial insurance coverage for seniors, 41 percent of Canadian seniors are missing their annual eye exam. 

The survey found that the cost of eyewear remains a barrier for many seniors, causing them to delay their exams, creating concern among eyecare providers. Missed exams can lead to undiagnosed eye conditions that can cause significant damage to vision, the survey said.

Half of Canadian seniors do not have vision health benefits and one in four have skipped or delayed updating their eyewear prescriptions due to financial barriers, putting seniors' vision at risk, according to the survey.

Subsequent health complications due to these risks are one of the major drivers behind the need for seniors to get regular eye exams. According to Specsavers, one-in-five seniors do not know their family's eye health history and may not be aware of their increased risk of vision-threatening diseases, such as glaucoma and age-related macular degeneration (AMD).

According to Specsavers, many in the industry are calling for a national strategy for eyecare, through the proposed Bill C-284, to ensure better health outcomes for Canadians. This is particularly important for senior populations who are more likely to be diagnosed with eye diseases such as glaucoma and AMD.

WestGroupe Partners With University of Waterloo School of Optometry & Vision Science to Fuel Innovation in Vision Care

By Staff
Wednesday, May 15, 2024 12:18 AM MONTREAL—WestGroupe, a family-operated optical company headquartered here, has announced a donation of $15,000 (CAD) and ongoing partnership to support the efforts of the Waterloo Eye Institute (WEI).

Alimera Sciences Reports Financial Results for First Quarter of 2024

By Staff
Wednesday, May 15, 2024 12:15 AM ATLANTA—Alimera Sciences, Inc., a global pharmaceutical company specializing in retinal health, has announced financial results for the first quarter of 2024. The company reported net revenue of $23.0 million, up 70 percent compared with the prior-year quarter.

Lensar Reports First Quarter 2024 Results and Provides Business Update

By Staff
Tuesday, May 14, 2024 12:21 AM ORLANDO, Fla.—Lensar, Inc. (Nasdaq: LNSR), a medical technology company focused on femtosecond laser treatment of cataracts, has announced financial results for the quarter ended March 31, 2024, and provided an update on key operational initiatives.

Prevent Blindness to Host the 2024 ASPECT Patient Engagement and Advocacy Summit May 14-16 in Washington, D.C.

By Staff
Monday, May 13, 2024 12:27 AM WASHINGTON, D.C.—Prevent Blindness, a nonprofit eye health and safety organization, announced that it will host the ASPECT Patient Engagement and Advocacy Summit, May 14-16, 2024, at the Madison Hotel in Washington, D.C. The Summit will bring together ASPECT (Advocacy, Support, Perspective, Empowerment, Communication, and Training) Patient Engagement Program graduates and program sponsors. As part of the event, Prevent Blindness will also hold its 19th Annual Eyes on Capitol Hill legislative day, providing participants with the opportunity to meet elected officials and their staff to discuss public policy and federal funding requests, the announcement stated.

VSP Vision Partners With HUED to Provide Cultural Competency and Humility Training for Network Doctors

By Staff
Monday, May 13, 2024 12:24 AM RANCHO CORDOVA, Calif.—VSP Vision, an eye health company with a focus on delivering access to health-centric vision care, and HUED, a learning and development company that creates equitable and inclusive health care content, have announced a partnership to offer cultural competency and humility training at no cost for VSP network doctors. Optometrists who complete the training will receive a continuing education credit (CE), council on optometric practitioner education (COPE) accreditation, and placement on the HUED Directory of Increased Visibility as a culturally competent and humbled provider.

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

By Staff
Monday, May 13, 2024 12:21 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, has reported its financial results for the three months ended March 31, 2024. Net product sales for the first quarter of 2024 were $2.6 million

KITS Eyecare Reports Record First Quarter 2024 Results

By Staff
Monday, May 13, 2024 12:18 AM VANCOUVER, British Columbia—KITS Eyecare Ltd., a leading vertically integrated eyecare provider, has reported its results for the first quarter ended March 31, 2024. Revenue increased by 26 percent to $34.8 million.

Clearside Biomedical Announces First Quarter 2024 Financial Results

By Staff
Monday, May 13, 2024 12:15 AM ALPHARETTA, Ga.—Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, has reported financial results for the first quarter ended March 31, 2024.

Spring and Summer COVID

By Staff
Friday, May 10, 2024 1:05 PM Doctors and researchers are closely watching a new COVID variant called KP.2, monitoring what its spread might mean for the Spring and Summer seasons. Head over to The New York Times for more. 

Myopia Awareness Week Calls Attention to Global Eye Health Concern

By Daniel Breeman
Friday, May 10, 2024 8:30 AM The numbers are overwhelming and still climbing. Myopia is growing around the world, with a recent study estimating that on average, 30 percent of the world is currently myopic, and by 2050 almost 50 percent (5 billion people) will be myopic, according to the International Myopia Institute. Myopia prevalence is also rising in the U.S., with a reported prevalence of 42 percent, a number that has almost doubled in three decades. The week of May 13-19 has been designated as Myopia Awareness Week 2024, a global event that aims to raise awareness about juvenile-onset myopia and encourage eyecare professionals to take necessary actions.

Warby Parker Announces Strong First Quarter 2024 Results and Raises Full-Year Guidance

By Staff
Friday, May 10, 2024 12:27 AM NEW YORK—Warby Parker Inc. (NYSE: WRBY), has announced financial results for the first quarter ended March 31, 2024. Net revenue increased $28.0 million, or 16.3 percent, to $200.0 million, as compared with the prior-year period. The company also announced that average revenue per customer increased 9.6 percent year-over-year to $296 with increased active customer growth of 3.2 percent to 2.36 million.